CKD 5D Asia—what is common and what is different from the West?
Abstract The mission of Kidney Disease: Improving Global Outcomes (KDIGO) is to improve the care and outcomes of kidney disease patients worldwide through the development and implementation of global clinical practice guidelines (CPG). To attain this mission, KDIGO has been publishing CPGs since 200...
Main Author: | Kunitoshi Iseki |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-09-01
|
Series: | Renal Replacement Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41100-018-0175-6 |
Similar Items
-
Clinical Significance of Adropin and Afamin in Evaluating Renal Function and Cardiovascular Health in the Presence of CKD-MBD Biomarkers in Chronic Kidney Disease
by: Rupinder Kaur, et al.
Published: (2023-10-01) -
Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease
by: Ariane Zaloszyc, et al.
Published: (2023-03-01) -
Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4–5 KDIGO without renal replacement therapy: a double-blind randomized HEBE-CKD trial
by: Fabio Solis-Jimenez, et al.
Published: (2022-09-01) -
The Off-Target Effects, Electrolyte and Mineral Disorders of SGLT2i
by: Giuseppe Cianciolo, et al.
Published: (2020-06-01) -
Recomendaciones de la Sociedad Española de Nefrología para el manejo de las alteraciones del metabolismo óseo-mineral en los pacientes con enfermedad renal crónica: 2021 (SEN-MM)
by: José-Vicente Torregrosa, et al.
Published: (2022-12-01)